Secondary Logo

​​​2019 Excellence in Oncology Award​

Oncology Times is proud to announce the winners of the 2019 Excellence in Oncology Award ; an exciting contest designed to recognize the wonderful research, dedication, and dramatic impact on patients (and their families) that occur every day in oncology.

2019 Excellence in Oncology Winner: Adoptive T-Cell Therapy Safe & Effective for Patients With PML
Katy Rezvani, MD, PhD, at The University of Texas MD Anderson Cancer Center, and her team has been recognized for her phase II, proof-of-concept study showed that adoptive T-cell therapy is a safe and effective approach to treating progressive multifocal leukoencephalopathy in immunosuppressed patients.

First Runner-up: Minimally Invasive Versus Abdominal Radical Hysterectomy for Cervical Cancer; Survival After Minimally Invasive Radical Hysterectomy for Early-Stage Cervical Cancer

Lead authors: Pedro Ramirez, MD, and Alejandro Rauh-Hain, MD, MPH, MD Anderson Cancer Center

Second Runner-up: Curing Patients With CNS Neuroblastoma Metastases

Lead author: Kim Kramer, MD, Memorial Sloan Kettering Cancer Center

Honorable Mentions

Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain
Lead researcher: Hussein A. Tawbi, MD, PhD, MD Anderson Cancer Center

Convection-Enhanced Delivery for Diffuse Intrinsic Pontine Glioma: a Single-Centre, Dose-Escalation, Phase 1 Trial
Lead researcher: Mark M. Souweidane, MD, Weill Cornell Medicine and NewYork-Presbyterian

Practice Transformation—Early Impact of OCM on Hospital Admissions
Lead researcher: David M. Waterhouse, MD, MPH, Oncology Hematology Care, Inc.


2018 Excellence in Oncology Recipients